Insider Trading activities of Omrix Biopharmaceuticals, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Omrix Biopharmaceuticals, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Omrix Biopharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Omrix Biopharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is OMRI. The reporting company's CIK number is 1349426.
The total value of stock buying since 2005 is $1,500,147.
The total value of stock sales since 2005 is $34,613,915.
The total value of stock option exercises since 2005 is $1,904,627.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Omrix Biopharmaceuticals, Inc. (OMRI).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2008-03 117,990 $1,461,137 0 $0 0 $0
2008-01 0 $0 113,637 $3,895,361 113,637 $744,542
2007-12 0 $0 9,091 $345,458 9,091 $194,001
2007-11 0 $0 9,000 $337,590 9,000 $146,969
2007-08 0 $0 2,750 $81,097 2,750 $33,742
2007-06 0 $0 51,000 $1,725,199 54,467 $364,075
2007-01 0 $0 102,391 $3,079,921 0 $0
2006-12 0 $0 750,000 $22,559,999 0 $0
2006-11 0 $0 42,728 $976,334 42,728 $421,298
2006-10 0 $0 81,205 $1,612,956 0 $0
2006-05 2,000 $28,770 0 $0 0 $0
2006-04 1,000 $10,240 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Omrix Biopharmaceuticals, Inc. insiders (OMRI)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2008-03-31 Mashiach Nissim (President and COO) Buy 2,000 14.50 29,000
2008-03-26 Romagnoli Philippe (Director) Buy 7,800 13.59 106,002
2008-03-26 Rakin Kevin (Director) Buy 2,000 13.65 27,292
2008-03-20 Taub Robert (Chief Executive Officer) Buy 26,400 12.10 319,519
2008-03-20 Romagnoli Philippe (Director) Buy 8,250 12.02 99,198
2008-03-19 Taub Robert (Chief Executive Officer) Buy 53,600 12.31 659,655
2008-03-19 Romagnoli Philippe (Director) Buy 13,940 12.24 170,555
2008-03-18 Droppert V. Marc (Executive Vice President) Buy 4,000 12.48 49,916
2008-01-04 Burshtine Michael (Other) Sale 32,665 34.00 1,110,610
2008-01-04 Burshtine Michael (Other) Option Ex 32,665 6.19 202,196
2008-01-03 Burshtine Michael (Other) Sale 10,881 34.02 370,117
2008-01-03 Burshtine Michael (Other) Option Ex 10,881 9.97 108,483
2008-01-02 Burshtine Michael (Other) Sale 70,091 34.45 2,414,634
2008-01-02 Burshtine Michael (Other) Option Ex 70,091 6.19 433,863
2007-12-11 Mashiach Nissim (Senior VP, Operations) Sale 9,091 38.00 345,458
2007-12-11 Mashiach Nissim (Senior VP, Operations) Option Ex 9,091 21.34 194,001
2007-11-08 Prado Nanci (General Counsel) Sale 9,000 37.51 337,590
2007-11-08 Prado Nanci (General Counsel) Option Ex 9,000 16.33 146,969
2007-08-13 St Peter Steven (Director) Sale 2,750 29.49 81,097
2007-08-13 St Peter Steven (Director) Option Ex 2,750 12.27 33,742
2007-06-29 Horowitz Bernard (Director) Option Ex 2,750 12.27 33,742
2007-06-06 Horowitz Bernard (Director) Option Ex 2,717 10.00 27,170
2007-06-05 Horowitz Bernard (Director) Sale 2,000 34.50 69,000
2007-06-04 Price Fredric D (Director) Sale 49,000 33.80 1,656,199
2007-06-04 Price Fredric D (Director) Option Ex 49,000 6.19 303,163
2007-01-17 Taub Robert (Pres., Chief Executive Officer) Sale 102,391 30.08 3,079,921
2006-12-20 Taub Robert (Pres., Chief Executive Officer) Sale 682,606 30.08 20,532,788
2006-12-20 Romagnoli Philippe (Vice President and Secretary) Sale 67,394 30.08 2,027,211
2006-11-09 Mashiach Nissim (Senior VP, Operations) Sale 42,728 22.85 976,334
2006-11-09 Mashiach Nissim (Senior VP, Operations) Option Ex 42,728 9.86 421,298
2006-10-24 Evnin Luke (10% Owner) Sale 21,402 19.76 422,817
2006-10-24 Gadicke Ansbert (10% Owner) Sale 15,095 19.76 298,216
2006-10-23 Evnin Luke (10% Owner) Sale 30,483 19.95 608,135
2006-10-23 Gadicke Ansbert (10% Owner) Sale 14,225 19.95 283,788
2006-05-16 Horowitz Bernard (Director) Buy 1,000 14.20 14,200
2006-05-15 Horowitz Bernard (Director) Buy 1,000 14.57 14,570
2006-04-24 Horowitz Bernard (Director) Buy 1,000 10.24 10,240

Insider trading activities including stock purchases, stock sales, and option exercises of OMRI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Omrix Biopharmaceuticals, Inc. (symbol OMRI, CIK number 1349426) see the Securities and Exchange Commission (SEC) website.